Zevacor   Report issue

For profit Phase 3
Founded: Noblesville IN United States (1986)
Status: Acquired by Sofie (2017)

Organization Overview

First Clinical Trial
2014
NCT02260817
First Marketed Drug
2014
sodium fluoride-18f
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

GLOBAL ISOTOPES LLC